APO RESEARCH · REPORT
Drugs for Malaria
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Product & engineering
Understand the product.
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
Selected research
Industry Growth & Trends
Global Drugs for Malaria Industry Growth and Trends Forecast to 2032
Market perspective
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, the global Drugs for Malaria market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Drugs for Malaria market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drugs for Malaria market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs for Malaria market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs for Malaria.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Drugs for Malaria market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drugs for Malaria Market by Company
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Drugs for Malaria Segment by Type
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Drugs for Malaria Segment by Application
Prevention
Treatment
Others
Drugs for Malaria Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drugs for Malaria companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
Applications
- Prevention
- Treatment
- Others
Companies covered
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Drugs for Malaria Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Drugs for Malaria Market Size by Region (2021-2032)
- 1.4.1 Global Drugs for Malaria Market Size by Region (2021-2026)
- 1.4.2 Global Drugs for Malaria Market Size by Region (2027-2032)
- 1.5 Key Regions Drugs for Malaria Market Size (2021-2032)
- 1.5.1 North America Drugs for Malaria Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Drugs for Malaria Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Drugs for Malaria Market Size Growth Rate (2021-2032)
- 1.5.4 South America Drugs for Malaria Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Drugs for Malaria Market Size Growth Rate (2021-2032)
2 Drugs for Malaria Market by Type
- 2.1 Type Introduction
- 2.1.1 Aryl Aminoalcohol Compounds
- 2.1.2 Antifolate Compounds
- 2.1.3 Artemisinin Compounds
- 2.2 Global Drugs for Malaria Market Size by Type
- 2.2.1 Global Drugs for Malaria Market Size Overview by Type (2021-2032)
- 2.2.2 Global Drugs for Malaria Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Drugs for Malaria Market Size Forecasted by Type (2027-2032)
- 2.3 Global Drugs for Malaria Market Size by Regions
- 2.3.1 North America Drugs for Malaria Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Drugs for Malaria Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Drugs for Malaria Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Drugs for Malaria Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Drugs for Malaria Market Size Breakdown by Type (2021-2026)
3 Drugs for Malaria Market by Application
- 3.1 Type Introduction
- 3.1.1 Prevention
- 3.1.2 Treatment
- 3.1.3 Others
- 3.2 Global Drugs for Malaria Market Size by Application
- 3.2.1 Global Drugs for Malaria Market Size Overview by Application (2021-2032)
- 3.2.2 Global Drugs for Malaria Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Drugs for Malaria Market Size Forecasted by Application (2027-2032)
- 3.3 Global Drugs for Malaria Market Size by Regions
- 3.3.1 North America Drugs for Malaria Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Drugs for Malaria Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Drugs for Malaria Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Drugs for Malaria Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Drugs for Malaria Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Drugs for Malaria Industry Trends
- 4.2 Drugs for Malaria Industry Drivers
- 4.3 Drugs for Malaria Industry Opportunities and Challenges
- 4.4 Drugs for Malaria Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Drugs for Malaria Revenue (2021-2026)
- 5.2 Global Drugs for Malaria Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Drugs for Malaria Key Company Headquarters & Area Served
- 5.4 Global Drugs for Malaria Company, Product Type & Application
- 5.5 Global Drugs for Malaria Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Drugs for Malaria Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2025
- 5.6.3 2025 Drugs for Malaria Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Cipla
- 6.1.1 Cipla Company Information
- 6.1.2 Cipla Business Overview
- 6.1.3 Cipla Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Cipla Drugs for Malaria Product Portfolio
- 6.1.5 Cipla Recent Developments
- 6.2 Guilin Pharmaceutical
- 6.2.1 Guilin Pharmaceutical Company Information
- 6.2.2 Guilin Pharmaceutical Business Overview
- 6.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
- 6.2.5 Guilin Pharmaceutical Recent Developments
- 6.3 IPCA Laboratories
- 6.3.1 IPCA Laboratories Company Information
- 6.3.2 IPCA Laboratories Business Overview
- 6.3.3 IPCA Laboratories Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
- 6.3.5 IPCA Laboratories Recent Developments
- 6.4 GlaxoSmithKline
- 6.4.1 GlaxoSmithKline Company Information
- 6.4.2 GlaxoSmithKline Business Overview
- 6.4.3 GlaxoSmithKline Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
- 6.4.5 GlaxoSmithKline Recent Developments
- 6.5 Mylan Labs
- 6.5.1 Mylan Labs Company Information
- 6.5.2 Mylan Labs Business Overview
- 6.5.3 Mylan Labs Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Mylan Labs Drugs for Malaria Product Portfolio
- 6.5.5 Mylan Labs Recent Developments
- 6.6 Roche
- 6.6.1 Roche Company Information
- 6.6.2 Roche Business Overview
- 6.6.3 Roche Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Roche Drugs for Malaria Product Portfolio
- 6.6.5 Roche Recent Developments
- 6.7 Novartis
- 6.7.1 Novartis Company Information
- 6.7.2 Novartis Business Overview
- 6.7.3 Novartis Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Novartis Drugs for Malaria Product Portfolio
- 6.7.5 Novartis Recent Developments
- 6.8 Sanofi Aventis
- 6.8.1 Sanofi Aventis Company Information
- 6.8.2 Sanofi Aventis Business Overview
- 6.8.3 Sanofi Aventis Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
- 6.8.5 Sanofi Aventis Recent Developments
- 6.9 Ajanta Pharma
- 6.9.1 Ajanta Pharma Company Information
- 6.9.2 Ajanta Pharma Business Overview
- 6.9.3 Ajanta Pharma Drugs for Malaria Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
- 6.9.5 Ajanta Pharma Recent Developments
7 North America
- 7.1 North America Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Drugs for Malaria Market Size by Country (2021-2026)
- 7.3 North America Drugs for Malaria Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Drugs for Malaria Market Size by Country (2021-2026)
- 8.3 Europe Drugs for Malaria Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Drugs for Malaria Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Drugs for Malaria Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Drugs for Malaria Market Size by Country (2021-2026)
- 10.3 South America Drugs for Malaria Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drugs for Malaria Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Drugs for Malaria Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Drugs for Malaria Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst